Clinical and imaging characteristics of 53 ulcers of post-radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma

Por Yan, Fengqin, Ye, Zhimin, Wang, Fangzheng, Wang, Lei, Li, Weiyang, Fu, Zhenfu
Publicado no Mol Clin Oncol (2016)

miR-195 is a key regulator of Raf1 in thyroid cancer

Por Wang, Fangzheng, Jiang, Chuner, Sun, Quanquan, Yan, Fenqin, Wang, Lei, Fu, Zhenfu, Liu, Tongxin, Hu, Fujun
Publicado no Onco Targets Ther (2015)

Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors

Por Ye, Zhimin, Fang, Jun, Dai, Shujun, Xie, Tieming, Wang, Fangzheng, Wang, Zhun, Li, Kai, Fu, Zhenfu, Wang, Yuezhen
Publicado no Oncotarget (2017)

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy...

Por Wang, Fangzheng, Jiang, Chuner, Ye, Zhimin, Liu, Tongxin, Sun, Quanquan, Yan, Fengqin, Qin, Weifeng, Fu, Zhenfu, Jiang, Yangming
Publicado no Transl Oncol (2017)

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced na...

Por Wang, Fangzheng, Sun, Quanquan, Jiang, Chuner, Liu, Tongxin, Rihito, Aizawa, Masoto, Sakamoto, Wang, Yuezhen, Fu, Zhenfu, Chen, Ming
Publicado no J Cancer (2018)

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma

Por Wang, Fangzheng, Jiang, Chuner, Ye, Zhiming, Sun, Quanquan, Liu, Tongxin, Xu, Min, Wu, Peng, Shi, Kaiyuan, Long, Bin, Fu, Zhenfu, Jiang, Yangming
Publicado no Transl Oncol (2018)

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma

Por Wang, Fangzheng, Jiang, Chuner, Ye, Zhimin, Sun, Quanquan, Liu, Tongxin, Xu, Min, Wu, Peng, Shi, Kaiyuan, Long, Bin, Rihito, Aizawa, Masoto, Sakamoto, Fu, Zhenfu
Publicado no Oncotarget (2017)